alexa
Reach Us +447480022765
Mycobacterium neoaurum Causing Prosthetic Valve Endocarditis | OMICS International
ISSN: 2161-105X
Journal of Pulmonary & Respiratory Medicine

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Mycobacterium neoaurum Causing Prosthetic Valve Endocarditis

Anupam Kumar*

University of Connecticut Health Center, USA

*Corresponding Author:
Anupam Kumar
University of Connecticut Health Center
263 Farmington Ave Farmington, 06030 CT, USA
E-mail: [email protected]

Received date: January 28, 2013; Accepted date: August 23, 2013; Published date: August 25, 2013

Citation: Anupam Kumar (2013) Mycobacterium neoaurum Causing Prosthetic Valve Endocarditis. J Pulmon Resp Med S14:006. doi:10.4172/2161-105X.S14-006

Copyright: © 2013 Anupam Kumar. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Pulmonary & Respiratory Medicine

Case Report

A 30 year old Caucasian male presented to the emergency department with shortness of breath and palpitations of 2 weeks duration associated with fever and chills. His past medical history was significant for multiple episodes of MRSA endocarditis in the setting of intravenous drug use, for which he had undergone bovine mitral valve replacement a year prior. He admitted to continued intravenous drug use despite recurrent endocarditis and valve replacement. His vital signs on admission were temperature of 101.4°F, pulse rate of 106 per minute, blood pressure of 98/58 mm Hg and respiratory rate of 20 per minute. A Grade 3/6 holosystolic murmur was heard best at the mitral area and radiated to the axilla. The lower extremities were warm to touch. Distal pulses were intact and symmetric. A detailed neurological exam was unremarkable. Admission laboratory tests showed a WBC count of 16.8K/mm3 with neutrophil predominance (84%). Serum electrolytes, blood urea nitrogen, creatinine, creatine kinase (CK) and liver function tests were within the normal range. Chest x-ray showed no abnormality, and electrocardiogram showed normal sinus rhythm with mild left atrial enlargement.

Blood cultures were drawn and the patient was started on empiric antibiotic therapy with vancomycin, ceftriaxone and rifampin for provisional diagnosis of prosthetic valve endocarditis. A transthoracic echocardiogram revealed extensive vegetations on the prosthetic mitral valve with mild obstruction to mitral inflow and a normal ejection fraction (Figure 1). The gram stain of the blood smear was initially reported as rods with both gram positive and gramnegative characteristics (Figure 2). However, the acid-fast stain turned positive and three blood culture bottles (aerobic) eventually grew Mycobacterium species (Figure 3). The organism was further identified as Mycobacterium neoaurum using the 16s ribosomal DNA sequencing method. The patient was treated with an anti-mycobacterial regimen based on susceptibility data: IV tobramycin, oral azithromycin and oral moxifloxacin. On day ten of his hospital stay he developed severe abdominal pain. CT scan of the abdomen revealed a splenic infarct (Figure 4) as well as left renal infarct (Figure 5). MRI of brain revealed one centimeter brain abscess (Figure 6). Surgical intervention was discouraged given his ongoing drug use. The patient’s condition improved remarkably within the next few days. His repeat blood cultures were negative on day 4 and his symptoms resolved. Although it was advised that he continue the same antimicrobial regimen for an extended period of time, he was unwilling to do so. He was finally discharged on day 39 on a regimen of oral azithromycin, ethambutol and moxifloxacin. The patient was lost to follow up. He was readmitted a year later for prosthetic valve endocarditis due to coagulase negative staphylococcal species.

pulmonary-respiratory-prosthetic-mitral-valve

Figure 1: Echocardiogram showing vegetations on the prosthetic mitral valve with mild obstruction to mitral inflow.

pulmonary-respiratory-organism-gram-positive

Figure 2: Gram stain showing organism with gram positive and gram negative characteristics.

pulmonary-respiratory-Ziehl-Neelsen-staining

Figure 3: Ziehl Neelsen staining demonstrating acid fast organisms suggestive of mycobacteria species.

pulmonary-respiratory-abdomen-showing

Figure 4: CT scan of abdomen showing infarct of the spleen.

pulmonary-respiratory-left-renal-infarct

Figure 5: CT scan of the abdomen showing left renal infarct.

pulmonary-respiratory-MRI-scan-brain

Figure 6: MRI scan of brain shows 1 cm brain abscess on the left.

Discussion

Infective endocarditis due to mycobacterium species is an unusual but well defined clinical entity. Nontuberculous mycobacteria (NTM) have been reported more frequently as a cause of infective endocarditis than Mycobacterium tuberculosis, especially of prosthetic valves [1,2]. The previously identified causative NTM species have included the following rapidly growing mycobacteria: M. fortuitum, M. abscessus, and M. chelonae [2,3]. M. neoaurum, a member of the Mycobacterium parafortuitum complex, has not been reported previously to cause infective endocarditis.

Mycobacterium neoaurum has been reported rarely as a cause of bloodstream infections in immunocompromised hosts, such as patients with malignancies or transplant recipients [4]. M. neoaurum has also been implicated in pulmonary infections [5], meningoencephalitis [6], urinary tract infection [7] and catheter related infections [4,8].

NTM PVE has been described in both mechanical and biologic valvular prostheses. Although the origin of NTM infection of prosthetic valves is unclear, the most recent reports suggest a nosocomial source [9]. A recently proposed mechanism is the contamination of the prosthetic valve before or during the surgical procedure [3]. Many rapidly growing mycobacteria have been noted to contaminate water systems in hospitals: water supplies to operating rooms, sterilization fluids, cardioplegic and valve preservation solutions [3,4]. This is likely due to the organism’s relative resistance to chemical decontamination. The indolent nature of these mycobacteria also allows for the delayed onset of symptoms and signs in cases of PVE in which perioperative contamination was suspected [3]. However, reports of M. neoaurum contaminating hospital water systems are not available at this time [4,10]. It is unclear how the prosthetic valve of our patient was infected with this organism. Mycobacterium neoaurum is found in the environment, and may likely have gained access to the bloodstream via breaks in the skin during intravenous drug use.

M. neoaurum can be detected on routine aerobic blood culturing systems and typically grows within 5 days on Lowenstein-Jensen agar. In many of the reported cases of endocarditis due to NTM the blood cultures were negative. The identification of the NTM was obtained by culturing the removed prosthetic valve, or by histopathologic analysis in conjunction with molecular assays. The advanced methods for identification include high-pressure liquid chromatography and sequencing of a unique 16S ribosomal RNA [11]. Therefore, if blood cultures are negative in a patient suspected of having PVE, definitive diagnosis can be made by removal of the infected prosthetic valve and performance of the aforementioned studies. In an immunocompromised patient with unexplained fever, isolation of M. neoaurum, particularly in multiple specimens, should be considered highly suggestive of infection with this organism.

Susceptibility testing of rapidly growing mycobacteria can be clinically useful, although it is not standardized and results are often delayed well into empiric therapy. Presently, the minimum recommendations for antibiotic susceptibility testing of rapidly growing NTM include clarithromycin, amikacin, cefoxitin, imipenem (the carbapenem preferred over meropenem and ertapenem), tobramycin, doxycycline, linezolid, ciprofloxacin, and sulfonamides [12]. Ciprofloxacin resistance is now widely encountered; however, moxifloxacin should be tested as some NTM isolates remain susceptible to this fluoroquinolone. M. neoaurum has a better susceptibility profile compared with M. chelonae and M. abscessus. However, a recent study did demonstrate high Mycobacterium neoaurum resistance to clarithromycin [12]. Combination antimicrobial therapy including macrolides, fluoroquinolones and aminoglycosides is the preferred treatment regimen.

Successful treatment of M. neoaurum bloodstream infection most commonly requires several weeks of combination antimicrobial therapy and removal of prosthetic material. Despite these complex treatment regimens and removal of prosthetic material, the prognosis of the affected individuals with NTM PVE is poor. However, in contrast with patients who have PVE due to other NTM, our patient responded very well to antibiotic treatment. This could be due to the indolent nature and low pathogenicity of M. neoaurum. This is further corroborated by the fact that the majority of patients who had infections of indwelling catheters due to M. neoaurum responded very well to antibiotics and catheter removal.

In conclusion, NTM PVE is a rare clinical entity that should be considered in patients with prosthetic valves who present with symptoms of endocarditis with negative blood cultures. M. neoaurum is a rapidly growing NTM that can cause infective endocarditis in immunosuppressed individuals. Whether it can be nosocomially transmitted is yet to be proven. NTM PVE due to M. neoaurum, in contrast to PVE due to other NTM, may be amenable to long term antibiotic therapy, especially if combined with prosthesis removal. In the absence of definitive regimens and substantial experience, physicians can rely on antibiotic susceptibility data and previous case reports to guide their antibiotic choice and duration of therapy. In general, however, endocarditis secondary to NTM, particularly involving the prosthetic valves, carries a poor prognosis.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 12424
  • [From(publication date):
    specialissue-2013 - Nov 15, 2019]
  • Breakdown by view type
  • HTML page views : 8617
  • PDF downloads : 3807
Top